TG Therapeutics TGTX Current ratio

Current ratio at other companies

BiogenBIIB

1.9×-0.6×

Rhythm Pharmaceuticals, Inc.RYTM

4.2×+0.9×

Mirum Pharmaceuticals, Inc.MIRM

2.9×-0.3×

Vor BiopharmaVOR

31.1×+27.3×

BridgeBio PharmaBBIO

1.5×-3.0×

Ultragenyx PharmaceuticalRARE

1.7×-0.7×

FAQ

What is TG Therapeutics's current ratio?

TG Therapeutics (TGTX) reported current ratio of 4.3× in Q2 2026.

How has TG Therapeutics's current ratio changed year-over-year?

TG Therapeutics's current ratio increased by 10.5% year-over-year, from 3.9× to 4.3×.

What is the long-term trend for TG Therapeutics's current ratio?

Over 5 years (2020 to 2025), TG Therapeutics's current ratio has grown at a -10.1% compound annual growth rate (CAGR), from 7× to 4.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.